Kestra Medical Technologies, Ltd.
KMTS
$24.24
-$0.75-3.00%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | 0.51% | 19.84% | 19.84% | ||
| Total Depreciation and Amortization | -43.86% | -9.61% | -9.61% | ||
| Total Amortization of Deferred Charges | -13.71% | 304.23% | 304.23% | ||
| Total Other Non-Cash Items | 19.95% | -31.10% | -31.10% | ||
| Change in Net Operating Assets | -91.67% | -1,484.54% | -1,484.54% | ||
| Cash from Operations | -16.38% | 14.38% | 14.38% | ||
| Capital Expenditure | 18.22% | -243.32% | -243.32% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | 18.17% | -269.86% | -269.86% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -100.00% | 106.80% | 106.80% | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 80.27% | 637.33% | 637.33% | ||
| Cash from Financing | -101.00% | 115.85% | 115.85% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -154.58% | 663.33% | 663.33% | ||